Delivery Order SPE2DB20D1100-SPE2DB25FC6C6
- Not listed
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a competitive delivery order by the Defense Logistics Agency on August 18, 2025, for the supply of dapagliflozin 10 mg tablets in quantities of 30 units. The contract carries a firm fixed price ceiling value of $39,193.68 and is scheduled for completion by August 19, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on September 10, 2025, for Dapagliflozin 10 mg tablets (30-count packaging) with a ceiling value of $91,388.22. This firm fixed-price contract, which carries an ultimate completion date of September 11, 2025, was competitively awarded without set-aside designation by the Defense Logistics Agency (DLA), a defense-focused federal procurement entity. The...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,376.58 to AmerisourceBergen Drug Corp for the supply of Dapagliflozin 10 mg tablets (30-count packaging) on August 4, 2025, with completion targeted for August 5, 2025. The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 10, 2025, for the supply of Dapagliflozin 5 mg tablets (30-count units) valued at $10,269.40 under a firm fixed price contract. This non-set-aside award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. The pharmaceutical product will be delivered...
- The Defense Logistics Agency awarded a delivery order valued at $10,115.26 to AmerisourceBergen Drug Corp for the supply of dapagliflozin 10 mg tablets in a quantity of 30s. The contract was issued on April 24, 2025, with an ultimate completion date of April 25, 2025, and utilized firm fixed-price pricing with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Dapagliflozin 10 mg tablets (30-count package) under a firm fixed-price contract valued at $1,722.16. This is a non-set-aside competitive award with an ultimate completion date of August 4, 2025, with performance to take place at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Dapagliflozin 10 mg tablets in quantities of 30 units, with a contract ceiling value of $10,763.89. This firm fixed-price delivery order, which reaches ultimate completion on August 14, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The award was competitively awarded with no set-aside...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 10, 2025, for the supply of Dapagliflozin 5 mg tablets in quantities of 30, valued at $1,646.96. This competitively awarded, firm fixed-price delivery order is part of AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. The contract carries no set-aside designation and is set for...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Dapagliflozin 10 mg tablets in a 30-count package at a ceiling value of $1,333.77. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 21, 2025. This delivery order is issued under...
- The Defense Logistics Agency awarded a $2,356.02 delivery order to AmerisourceBergen Drug Corp for Dapagliflozin 5 mg tablets (30-count units) on September 11, 2025, with completion targeted for September 12, 2025. This is a firm fixed-price, non-set-aside contract performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a small-value transaction under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FC6C6Delivery Order
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a $56,588.09 firm fixed price delivery order from the Defense Logistics Agency on May 30, 2025, for the supply of Dapagliflozin 10 mg tablets in quantities of 30. This non-set-aside contract represents a child order under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA Troop Support Medical (contract SPE2DX), valued at $999,999,999.00 through December 2026. The delivery order is scheduled for completion by June 2, 2025, with performance occurring at the contractor's Conshohocken, Pennsylvania facility. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen supplies a comprehensive range of medications and medical commodities to support military and veteran healthcare systems. This delivery order for Dapagliflozin, a diabetes management medication, exemplifies the company's role in fulfilling pharmaceutical supply requirements across the Defense Health Agency and other federal healthcare systems. AmerisourceBergen's competitive positioning in federal procurement is demonstrated through its extensive portfolio of deliveries spanning multiple therapeutic domains, from specialty medications to generic drugs, all consistently awarded through open competition without set-aside designations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $56.6k | 5/30/25 |